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276 Posture in adult inpatients with cystic ﬁbrosis
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Objective: To evaluate the short-term effects of musculoskeletal (MSK) physio-
therapy on posture, lung function and health related quality of life (HRQoL) in
adults with cystic ﬁbrosis admitted for a respiratory exacerbation.
Method: A single blind prospective randomised controlled design. Subjects were
recruited on admission and randomised to a treatment or control group. The
treatment group received MSK assessment and were given MSK treatment on
alternate days during their inpatient stay. The control group received normal
optimal care. A blinded, independent observer measured both groups on days 0,
5, 10 and before discharge. Posture using thoracic index (TI), lung function and
HRQoL (Brompton Cystic Fibrosis Questionnaire, BCFQ) were measured. Data
were analysed using descriptive statistics and linear regression.
Result: Fifty-three patients (57% male) mean age 27.6 years (SD 10.3), mean forced
expiratory volume in one second (FEV1) 1.05L (SD 0.8) were recruited. There were
no differences between the groups at baseline. The improvements in TI, FEV1 and
FVC were greater per unit time (shown by linear regression) in the treatment than
the control group with differences of 1 ratio unit, 0.2L and 0.4L respectively. The
control group showed an increase (worsening) in TI at 5 days. None of these were
statistically signiﬁcant. BCFQ improved statistically signiﬁcantly in the treatment
group (p = 0.04).
Conclusion: There were no statistically signiﬁcant differences in posture or lung
function between the two groups, but further work to determine the minimally
important clinical difference in TI may explain whether the improvements in
HRQoL could be due to postural improvements.
277 Thoracic kyphosis in cystic ﬁbrosis: a challenge for children?
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Rationale: Postural problems and declining lung function are evident in adults with
cystic ﬁbrosis. It has been assumed that these problems develop during childhood or
adolescence and are related. However, limited evidence is available to demonstrate
this.
Objectives: The aim of this study is to establish at what age thoracic kyphosis
becomes evident in children with cystic ﬁbrosis and to determine the relationship
between thoracic kyphosis and lung function.
Design and Method: This retrospective study uses 74 sets of annual review data
taken from children with cystic ﬁbrosis aged 8 to 16 years. Thoracic kyphosis is
measured using an alternative Cobb Method (2 line method on lateral chest x-ray),
lung function via spirometry and disease severity using the Shwachman scoring
system. Correlations between these measures and age are explored using Pearson’s
Product Moment Tests.
Results: Increased thoracic kyphosis is not widely evident in the study population
and there is no relationship between thoracic kyphosis and age. There is, however,
a relationship between lung function and degree of thoracic kyphosis in females.
This ﬁnding cannot be fully explained but it is consistent with the generally poorer
outcomes for females with cystic ﬁbrosis.
Conclusions: Thoracic kyphosis is not a signiﬁcant problem for young people with
cystic ﬁbrosis but can occur in speciﬁc cases. Monitoring is required to identify the
few cases that could beneﬁt from active intervention. Studies of older age groups
may bring further understanding of increasing thoracic kyphosis in people with
cystic ﬁbrosis.
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Physiotherapy management of cystic ﬁbrosis (CF) has evolved with many in-
ternational variations. Positive Expiratory Pressure (PEP) physiotherapy airway
clearance theory includes both volume change via collateral ventilation, and airway
stabilisation. Australian children with CF often start PEP prior to school commence-
ment, around 5 years of age. From infant diagnosis, this prospective investigation
(ACFBAL study) included records of physiotherapy approaches used in the ﬁrst
5 years. Baseline, exacerbation, routine and ﬁnal outcome reviews were analysed
separately. PEP alone or used as an adjunct was compared to other techniques.
170 children (Mean age 3.6 mths, SD 1.6) from 8 Australasian sites were enrolled.
62% of children used PEP during the study, median age of introduction 3.85 yrs
(IQR 2.65, 4.59; Range 0.23, 5.26). 44% used PEP at ﬁnal outcome. 12% of the
cohort were diagnosed with signiﬁcant tracheomalacia (TM) at some time, however
there was no association between barking or croupy coughs typically associated with
malacia. Only 7% of children with TM used PEP at ﬁnal outcome. 72% of PEP users
had a cough compared with 40% of the cohort. Reasons for early initiation of PEP
may include the presence of persistent cough, physiotherapist familiarity with PEP,
or unexpected bronchoscopy ﬁndings indicating need for changed therapy regimen.
Our expectation that early use of PEP would be associated with barking or croupy
cough; nocturnal cough, and/or malacia was not supported. Further systematic study
of this emerging trend is warranted, particularly where airway malacia is identiﬁed
in young children.
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Background: Due to a lack of published evidence, rather than safety concerns, the
BTS Guidelines (2009) recommend HFCWO is not utilised in acute exacerbation
in CF adults. The HFCWO (Vest System) has however, been effectively utilised
simultaneously with active techniques, such as ACBT and AD within our centre
during exacerbation.
Aim: To report use of HFCWO in addition to usual ACT during acute exacerbation.
To heighten awareness, promote discussion and enhance consideration of HFCWO.
Method: Audit was undertaken of 71 acute Rx episodes (range 3−35 days, mean
12 days) in 40 CF adults (28 males, 12 females), age 18−46 yrs (mean 35 yrs).
Results: Data collected included lung disease severity, mild (FEV1 > 70%),
n = 11/40 (27%), M7:F 4. Moderate disease (FEV1 41−70%) n = 20/40 (50%),
M11:F 9. Severe disease (FEV1  40%) n = 9/40 (23%) M6:F 3. ACT utilised
with HFCWO: ACBT, AD, PEP, Flutter, Acapella and NIV. No adverse effect on
O2 sats or HR pre/post Rx. Outcomes: FEV1 (% predicted, best in 12 mths), mean
increase 18% (range −6%, 56%), wet sputum weight increased in 90% patients.
Conclusion: HFCWO utilised simultaneously with usual ACT was well tolerated
and perceived of beneﬁt in 90% CF adults. In line with previous research improved
sputum clearance, patient satisfaction and no adverse effects or complications were
noted. Future study is required to adequately assess effectiveness of this approach,
which may beneﬁt CF adults during acute exacerbation.
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